Skip to main content
PLOS One logoLink to PLOS One
. 2023 Mar 31;18(3):e0283760. doi: 10.1371/journal.pone.0283760

What is associated with reported acute respiratory infection in children under 5 and PCV vaccination in children aged 1–36 months in Malawi? A secondary data analysis using the Malawi 2014 MICS survey

Justine Gosling 1,2, Tim Colbourn 1,*
Editor: Shinya Tsuzuki3
PMCID: PMC10065275  PMID: 37000716

Abstract

Introduction

Acute respiratory illness (ARI) is a leading cause of mortality in children under 5 (CU5) in Malawi and can be prevented with 3-dose pneumococcal conjugate vaccine (PCV). There has been no national study in Malawi that seeks to associate social economic factors leading to PCV vaccine uptake and reported acute respiratory infections (RARI). The objectives of our study were to do this.

Methods

We conducted a cross-sectional analysis of secondary data from the 2014 UNICEF Malawi Multiple Indicator Cluster Survey to construct mutlivariable logistic regression models for independent associations with PCV 1/2/3 immunisation and RARI.

Results

56% of CU5 in Malawi RARI in the 2 week recall period of the survey. Independent associations with reduced odds of RARI were central region living (OR 0.82, 95%CI (0.71–0.93)) middle (OR 0.84, (0.73–0.97)) fourth (OR 0.79, (0.68–0.92)) and richest wealth quintiles (OR 0.73, (0.60–0.88)). Using straw/shrubs for fuel was associated with increased RARI (OR 3.13, (1.00–9.79)). Among 1–36 month olds, in 2014, 93.3% received PCV1, 86.8% PCV2 and 77.0% PCV3. Between 2011–2014, the average age in months for a child to receive PCV1/2/3 reduced by 26.6 for PCV1, 26.4 for PCV2, and 26.1 for PCV 3. Independent predicators for increased odds of all 3 PCV doses, relative to 0–5 age group, were age group 6–11 (OR 21.8, (18.2–26.1) 12–23 (OR 27.5, (23.5–32.2) 24–36 months (OR 9.09, (7.89–10.5), mothers having a secondary (OR 1.52, (1.25–1.84)) or higher education (OR 2.68, (1.43–5.04) when compared to no education, and children in the middle (OR 1.24, (1.07–1.43)) fourth (OR 1.27, (1.09–1.48)) richest (OR 1.54, (1.27–1.88)) wealth quintiles relative to the lowest. Children living with 4–6 other children was independently associated with reduced odds of receiving all 3 PCV doses (OR 0.56, (0.33–0.96).

Conclusion

We report nationally representative social economic associations with RARI and PCV vaccine uptake and coverage estimates. We found reductions in the average age a child receives all 3 PCV vaccine doses between 2011–2014.

Introduction

In 2019, a child less than 5 years old died from pneumonia every 39 seconds [1]. Although numbers are declining, pneumonia persistently remains the leading infectious cause of death for children under 5 (CU5) globally, killing around 880,000 children in 2019 [1]. Current trends estimate that 735,000 children will die due to pneumonia in 2030 despite the Sustainable Development Goal (SDG) target 3.2,”ending preventable child deaths” [2].

Pneumonia diagnosis is strongly associated with a child’s socio-economic status. Evidence from Malawi demonstrates that rural dwelling [3, 4] malnourishment [5, 6] low income [6] and increasing household density [6, 7] are factors that predispose children to pneumonia.

Almost all pneumonia deaths are preventable through vaccination, early diagnosis and low cost treatment and care [8]. First licenced in 2000, the pneumococcal conjugate vaccine (PCV) is a safe and efficacious vaccine to Streptococcus bacterial infection [9]. PCV13 inhibits nasopharyngeal carriage reducing transmission, allowing for the herd effect [10]. In 2007 the World Health Organisation (WHO) published guidelines advising PCV be added to national immunization programmes as a key strategy for rapidly reducing deaths from pneumonia [11]. Distribution of Thirteen-valent PCV in Malawi began on November 12th 2011 and is offered to infants in 3 doses at 6, 10 and 14 weeks of age as part of routine immunization [12]. The introduction coincided with catch up vaccinations with infants over 12 months receiving 3 doses at 1-month intervals [10]. The vaccination is free of charge and studies have shown it to reduce cases of very severe pneumonia in children by 65% in both hospital and community cases in Malawi [7].

Malawian coverage estimates for all 3 PCV doses by 12 months old from data collected between 2012–2014 vary from 86% [13] 76% [7] increasing to 89.2% in 2015 [14] all just below the target for full immunisation set at >90% [15]. Munthali [16] stated that in Malawi it is considered the responsibility of a child’s mother to ensure they are vaccinated. The evidence is inconsistent on whether maternal education level impacts PCV uptake with region specific studies reporting no relationship [6] and others showing lower maternal education levels result in lower children’s vaccination rates [1618]. Higher vaccine coverage has been reported in large households [17] and in urban areas, likely due to greater access to health services [16]. Although pre PCV, Austin et al [18], demonstrated lower income households to be associated with incomplete vaccination in Malawi, which is consistent with reports that the poorest in society have less access to public health services [19]. No association has been found between sex and uptake of other childhood vaccines [20]. Again, not specific to PCV, Abebe et al [20], found regional vaccination coverage discrepancies with lower coverage in the northern region. Probably owing to its fairly recent introduction in 2011, there are no studies investigating associations with PCV vaccine uptake nationally, only regional studies.

Currently, rather than specify pneumonia, which is difficult to accurately diagnose based on symptoms in the field [21], UNICEF [22] promotes the term “Acute respiratory illness” (ARI) instead, an umbrella term for respiratory illness capturing pneumonia, comprising 2 symptoms: a cough and fast or difficulty in breathing. Based on this recommendation and because a survey is unable to diagnose pneumonia, this study will refer to reported acute respiratory illness (RARI) as our dependent variable definition encompassing the symptoms of pneumonia. ARI is widely used in research to define pneumonia in non-clinical settings [23].

Existing evidence suggests that rural Malawian children of lower social economic status are more likely to have RARI and less likely to be fully vaccinated with regional differences. To justify this study and research question, to date, there has been no study in Malawi that is generalisable nationally, that seeks to understand social economic factors associated with 1) PCV vaccine uptake and 2) RARI at household level. The existing evidence is limited to specific areas that is not generalisable or does not measure PCV since it was only introduced in November 2011. This study will be useful to understand the drivers of PCV vaccine uptake and social economic associations with RARI whilst estimating PCV vaccination coverage for 2014. Therefore, this study asks the question: What is associated with RARI in children under 5 and PCV vaccination in 1–36 month olds in Malawi?

Primary objectives of this study are to establish:

  1. National, social economic associations with RARI in children under 5.

  2. National, social economic associations with PCV uptake in children aged 1–36 months.

Methods

Research design

This study is a cross-sectional analysis of secondary data, utilising publicly available data from the 2014 UNICEF Malawi MICS, a country wide, 4 yearly household survey which monitors indicators of the lives and health of women and children in low income countries [24]. Anyone can access the data sets, however, researchers need to register with the MICS website to gain access. Individual informed consent was obtained at point of contact by the interviewers. The interviewer introduced themselves to the participant explaining that they were from the national statistics office and conducting a survey about the situation of children, families and households and asked for their consent to answer the questions [24]. Participants were reassured that information collected would remain confidential and anonymous [24].

Sampling

Within Malawi, each district was stratified into urban and rural strata, yielding 56 sampling strata across the country. From each strata a specified number of census enumeration areas were independently selected systematically, with probability proportional to size. This process resulted in 1,140 sample enumeration areas (SEAs) and 28,479 households to be included in the 2014 survey. To form a sampling frame, a household listing was conducted within all the SEAs and a sample of 30 households per urban cluster and 33 per rural cluster systematically drawn. In this survey, a cluster is either an SEA or a segment of an SEA. One cluster had to be excluded as flooding prevented access at the time of the survey. All permanent residents aged between 15–49 were eligible for interview.

Survey questionnaire

The MICS survey comprises 4 questionnaires. This study utilises the child questionnaire and a number of variables from the household questionnaire. The child questionnaire was administered to the caregivers of all residing children under 5. The English version was customised and translated into Chichewa and Tumbuka and was pre-tested with appropriate modifications made to suit the survey population [24].

Data collection

The survey was carried out between December 2013 and April 2014. Analysis of PCV can only be measured for 1–36 month olds as per available data from the MICS database and vaccine age criteria (there is no vaccination data on children aged 37–59 months). This age group permits children born after the introduction of the PCV in November 2011 up to the survey end date in April 2014.

Ethical approval

Ethical approval was not needed as MICS data is anonymised.

Measures

Field workers received 28 days of training to carry out the survey prior to implementation which included teachings on interviewing techniques, questionnaire contents and was finalised with mock interviews [24]. Data was collected by 32 teams comprising of 4 interviewers, a driver, editor, 1 measurer and a supervisor [24]. In addition to conducting questionnaires, fieldworkers measured the weights and heights of all CU5. Data was recorded using CSPro software, Version 5.0 and stored on 30 desktop computers. To reduce error, all questionnaires were double-entered and internally checked for consistency. Data processing ran simultaneously with data collection and was analysed using StataCorp [25].

Study variables

Dependent variables

  1. RARI of CU5. Recorded if the caregiver answered “yes” when asked if the child had experienced “Difficulty in breathing with cough” in the last 2 weeks.

  2. PCV1/2/3 vaccination status of children aged 1–36 months was obtained from vaccination record cards and, the absence of a vaccination card, caregiver recall.

Independent variables

We selected variables widely used in previous studies (see introduction) that aligned with our objectives.

From the children’s survey. Age in months, age in 6 month categories, Urban/rural living, geographical region, sex, mothers reported education level in 5 categories, wealth index in 5 categories and the child’s weight for height Z scores according to WHO standards.

The Weight for height Z score is widely accepted as the current, most representative and simple measure of malnutrition and its use is advised by the WHO [26]. Weight and height measures were collected and Z scores retrospectively calculated according to WHO standards and added to the data set [24]. Z scores express the anthropometric value as a number of standard deviations above or below the reference mean value and are independent of sex. This enables comparisons of a child’s growth and malnutrition status across age groups to be made [26].

The wealth index is constructed of components including the ownership of consumer goods such as a television, refrigerator, motorcycle/scooter and the characteristics of the dwelling such as access to water and sanitation facilities, to generate scores. Scores are generated for the total sample and then stratified for urban and rural areas. These 2 strata scores are then regressed on the score for the total sample to calculate the combined scores for the total population to minimise urban bias in the variable. A wealth score can then be calculated for each household which is ranked into one of 5 equal quintiles from lowest (poorest) to highest (richest). The wealth index is only applicable for the data set it is formed from [27].

From the household survey. Number of people residing in the house, number of children under 5 residing in the house, child’s birth order, location in residence for cooking and type of cooking fuel used.

Data analysis

The children’s data set was imported into Stata 16 and merged with the household data set [25]. To produce nationally representative results, sample weights provided in the datasets were used. Children with incomplete interviews were excluded from the initial sample (S1 Fig in S1 File). Chi Squared descriptive univariable analyses were conducted for RARI and PCV uptake to explore significant associations between the dependent variables and the social economic independent variables. A chi Squared analysis is appropriate for categorical data to statistically analyse frequency distribution [28].

More detailed analysis was then conducted with uni and multiple logistic regression models to adjust for independent confounding variables, calculating odds ratios (ORs) with a 95% confidence interval (CI) for RARI associations. Logistic regression analysis associates the ratio of the odds of an event occurring, given the value of an independent variable compared to the reference category of the independent variable, e.g. the odds of RARI if rural living compared to urban living. Multiple logistic regression models examine the impact of multiple variables accounting for several potentially confounding variables simultaneously and is the appropriate regression analysis when the dependent variable is binary [29] as in this instance. The same analysis was also completed comparing variables against PCV 1/2/3 doses. A p value of 0.05 or less (2 sided) was considered significant for all statistical tests. A p value quantifies the significance of an association and the 95% CI quantifies the preciseness of the estimation with a values range [30] for which if the study was repeated multiple times, the true effect would be within this range 95% of the time [31].

Results

Survey population

28,479 households were selected for the sample, 27,030 of which were occupied and 26,713 successfully interviewed, a response rate of 99 percent [24]. 19,285 CU5 were listed as eligible for interview in the children’s questionnaire, of which, 18,981 completed questionnaires and became the survey sample, a response rate of 98 percent (S1 Fig in S1 File).

Table 1 details the sample characteristics. The sample produced an almost equal male/female ratio with a mean average age of 29.9 months. 48.5% of the sample lived in the southern region, 34% central and 17.5% were from the northern region. 88.8% of the sample population was rural living. 13.3% of the children’s mothers has no education, 70.2% had primary level education, 15.4% secondary and less than 1% had received higher education. 23% of children were categorised in the poorest and 22% in the second poorest wealth quintiles. The middle wealth quintile comprised of 21.5% of the sample, 18.6% in the fourth richest and 15.1% were in the richest quintile. Positively, 96.2% of children scored ‘normal’ in the WHO standard weight for height scores. 52.8% of children lived with less than 5 people, 44.8% lived with less than 10. Less than 2.1% lived with more than 10 people but 43 (0.2%) children resided with more than 16. 99.3% of children lived with less than 4 other children. Of those with data, 43.1% of the children surveyed were the first child to be born to their mother and 25.5% were the second child born. For nearly 59% of households, food was cooked in a separate kitchen or outside (27.6%). Of those with data, 87.5% of households used wood as cooking fuel (Table 1).

Table 1. Sample characteristics.

Variable Measure Number of children Under 5 n = 18,981
Sex Male n = 9,490 (50%)
Female n = 9,491 (50%)
Missing 0
Region Northern n = 3,320 (17.5%)
Central n = 6,451 (34%)
Southern n = 9,210 (48.5%)
Missing 0
Area Urban n = 2,125 (11.2%)
Rural n = 16,856 (88.8%)
Missing 0
Age Mean average age of sample 29.9 months
0–5 months n = 1,686 (8.8%)
6–11 months n = 1,791 (9.4%)
12–23 months n = 3,870 (20.3%)
24–35 months n = 3,795 (19.9%)
36–47 months n = 4,099 (21.6%)
48–59 months n = 3,740 (19.7%)
Missing 0
Mothers education level None n = 2,528 (13.3%)
Primary n = 13,330 (70.2%)
Secondary n = 2,921 (15.4%)
Higher n = 188 (1%)
Missing n = 14 (0.07%)
Wealth quintile Poorest n = 4,290 (23%)
Second n = 4,190 (22%)
Middle n = 4,082 (21.5%)
Fourth n = 3,538 (18.6%)
Richest n = 2,881 (15.1%)
Missing 0
Weight for height Z score >-2 Zscores (normal) n = 18,269 (96.2%)
-3 to -2 Zscores (low) n = 508 (2.7%)
<3 Zscores (severely low) n = 204 (1.1%)
Missing 0
Number of people residing in household (from merged household data set) <5 n = 10,023 (52.8%)
6–10 n = 8,507 (44.8%)
11–25 n = 451 (2.4%)
Missing 0
Number of children under 5 residing in house (from merged household data set) 1–3 n = 18,840 (99.3%)
4–6 n = 141 (0.7%)
Missing 0
Childs birth order (from merged household data set) 1st n = 8,194 (43.2%)
2nd n = 4,846 (25.5%)
3rd n = 2,654 (14.0%)
4th n = 1,570 (8.3%)
5th n = 689 (3.6%)
6th n = 298 (1.6%)
7th n = 114 (0.6%)
8th n = 34 (0.2%)
Missing n = 582 (3.1%)
Location of cooking activities (from merged household data set) Separate kitchen room n = 1,553 (8.1%)
Elsewhere in house n = 883 (4.6%)
Separate building n = 11,128 (58.6%)
Outdoors n = 5,240 (27.6%)
Other n = 18 (0.1%)
Missing n = 159 (0.8%)
Cooking fuel used (from merged household data set) Electric n = 153 (0.8%)
Kerosene n = 1 (0.01%)
Coal n = 3 (0.02%)
Charcoal n = 2,142 (11.3%)
Wood n = 16,611 (87.5%)
Straw/shrubs n = 46 (0.2%)
Crops n = 18 (0.1%)
Other n = 1 (0.01%)
Missing n = 6 (0.03%)

RARI results

From the sample, 7,808 caregivers provided data on their children’s RARI. 4,382 caregivers answered “yes” to their child RARI in the 2 weeks prior to the interview date, 3,426 responded “no”, 11,173 results from the total CU5 sample were “missing” (S2 Fig in S1 File). Of the 11,173 missing data on RARI (variable CA8 “Difficulty breathing during illness with cough” in the MICS dataset, see questionnaire on page 637 of MICS [24]) only 4 responded “Don’t Know” and 10 were marked as “Missing” with the other 11,159 missing data on this variable in the dataset. We therefore don’t believe it’s correct to assume that those without data are “No” (i.e. don’t have RARI) and exclude them from our denominator. We report socio-economic characteristics of those with missing data on RARI separately in S1 Table in S1 File and find the proportion missing data on RARI only varies by 8 percentage points (e.g. for child age) or less across the categories of each socio-economic variable (S1 Table in S1 File), suggesting our analyses below are unlikely to be biased by this missing data. 56.2% of caregivers answering (4,382 / 7,808) RARI in their children in the 2 week interview recall period.

Of the 4,382 children answering yes to RARI, the 12–23 month old category reported the highest frequency of cases with 988 children affected. However, this age group was also the largest in the sample (see Fig 1). Statistical analysis did not find the 6 month age group categories to be significantly associated with RARI (p = 0.074, Table 2).

Fig 1. Presenting RARI frequency by age group in months.

Fig 1

Table 2. Socio-economic associations with RARI in children under 5.

Exposure variable Measure Chi squared uni variable analysis: RARI Chi Squared Uni- analysis (95% CI) Logistic regression analysis (95% CI) Multi logistic regression analysis (95% CI)**
Yes No
Sex Male n = 3,931 n = 2,218 (56.4%) n = 1,713 (43.6%) p = 0.589 OR = 1 -
Female n = 3,877 n = 2,164 (55.8%) n = 1,713 44.2%) OR 0.98
CI (0.89–1.07)
p = 0.589
Total n = 7,808 n = 4,382 (56.1%) n = 3,426 (43.9%)
Region Northern n = 1,486 n = 825 (55.5%) n = 661 (44.4%) p = 0.000* OR = 1 OR = 1
Central n = 2,614 n = 1,350 (51.6%) n = 1,264 (48.4%) OR 0.86 CI (0.75–0.97)
p = 0.017*
OR 0.82
CI (0.72–0.93)
p = 0.003*
Southern n = 3,708 n = 2,207 (59.5%) n = 1,501 (40.5%) OR 1.18
CI (1.04–1.33)
p = 0.008*
OR 1.12
CI (0.99–1.28)
p = 0.073
Total n = 7,808 n = 4,382 (56.1%) n = 3,426 (43.9%) - -
Area Urban n = 816 n = 397 (48.6%) n = 419 (51.3%) p = 0.000* OR = 1 OR = 1
Rural n = 6,992 n = 3,985 (57.0%) n = 3,007 (43.0%) OR 1.40
CI (1.21–1.62)
p = 0.000*
OR 1.14
CI (0.95–1.37)
p = 0.151
Total n = 7,808 n = 4,382 (56.1%) n = 3,426 (43.9%) - -
Age 0–5 months n = 632 n = 359 (56.8%) n = 273 (43.2%) p = 0.074 OR = 1 -
6–11 months n = 820 n = 472 (57.6%) n = 348 (42.4%) OR 1.03
CI (0.84–1.27)
p = 0.772
-
12–23 months n = 1,701 n = 998 (58.7%) n = 703 (41.3%) OR 1.08
CI (0.90–1.30)
p = 0.416
-
24–35 months n = 1,590 n = 869 (54.6%) n = 721 (45.3%) OR 0.92
CI (0.76–1.10)
p = 0.358
-
36–47 months n = 1,639 n = 918 (56%) n = 721 44.0%) OR 0.97
CI (0.80–1.17)
p = 0.732
-
48–59 months n = 1,426 n = 766 (53.7%) n = 660 (46.3%) OR 0.88
CI (0.73–1.07)
p = 0.194
-
Total n = 7,808 n = 4,382 (56.1%) n = 3,426 (43.9%) - -
Mothers education level None n = 861 n = 488 (56.7%) n = 373 (43.3%) p = 0.006* OR = 1 OR = 1
Primary n = 5,624 n = 3,204 (57.0%) n = 2,420 (43.0%) OR 1.01
CI (0.88–1.17)
p = 0.872
OR 1.08
CI (0.93–1.25)
p = 0.318
Secondary n = 1,232 n = 653 (53.0%) n = 579 (47.0%) OR 0.86
CI (0.72–1.03)
p = 0.097
OR 1.05
CI (0.87–1.26)
p = 0.617
Higher n = 82 n = 35 (42.7%) n = 47 (57.3%) OR 0.57
CI (0.36–0.90)
p = 0.016*
OR 0.87
CI (0.53–1.40)
p = 0.549
Total n = 7,799 n = 4,380 (56.2%) n = 3,419 (43.8%) - -
Wealth quintile Poorest n = 1,726 n = 1,027 (59.5%) n = 699 (40.5%) p = 0.000* OR = 1 OR = 1
Second n = 1,756 n = 1,040 (59.2%) n = 716 (40.8%) OR 0.99
(CI 0.86–1.13)
p = 0.868
OR 0.99
CI (0.86–1.13)
p = 0.866
Middle n = 1,672 n = 936 (56.0%) n = 736 (44.0%) OR 0.87
CI (0.76–0.99)
p = 0.038*
OR 0.86
CI (0.75–0.99)
p = 0.039*
Fourth n = 1,480 n = 804 (54.3%) n = 676 (45.7%) OR 0.81
CI (0.70–0.93)
p = 0.003*
OR 0.83
CI (0.71–0.96)
p = 0.010*
Richest n = 1,174 n = 575 (49.0%) n = 599 (51.0%) OR 0.65
CI (0.56–0.76)
p = 0.000*
OR 0.74
CI (0.61–0.89)
p = 0.002*
Total n = 7,808 n = 4,382 (56.1%) n = 3,426 (43.9%) - -
WHO Weight for height Z score >-2 Zscores (normal) n = 7,520 n = 4,213 (56.0%) n = 3,307 (44.0%) p = 0.594 OR = 1 -
-3 to -2 Zscores (low) n = 206 n = 119 (57.8%) n = 87 (42.2%) OR 1.07
CI (0.81–1.42)
p = 0.619
-
<3 Zscores (severely low) n = 82 n = 50 (61%) n = 32 (39%) OR 1.23
CI (0.79–1.92)
p = 0.370
-
Total n = 7,808 n = 4,382 (56.1%) n = 3,426 (43.9%) - -
Number of people residing in house <5 n = 4,204 n = 2,364 (56.2%) n = 1,840 (43.8%) p = 0.836 OR = 1 -
6–10 n = 3,430 n = 1,917 (55.9%) n = 1,513 (44.1%) OR 0.99
CI (0.90–1.08)
p = 0.764
-
11–25 n = 174 n = 101 (58.1%) n = 73 (42.0%) OR 1.08
CI (0.79–1.46)
p = 0.637
-
Total n = 7,808 n = 4,382 (56.1%) n = 3,426 (43.9%) - -
Number of children under 5 residing in house 1–3 n = 7,756 n = 4,351 (56.1%) n = 3,405 (43.9%) p = 0.611 OR = 1
4–6 n = 52 n = 31 (59.6%) n = 21 (40.4%) OR 1.16
CI (0.66–2.01)
p = 0.611
Totals n = 7,808 n = 4,382 (56.1%) n = 3,426 (43.9%) -
Childs birth order 1st n = 3,450 n = 1,957 (56.7%) n = 1,493 (43.3%) p = 0.053 treated as a linear variable. OR per unit increase: 1.00
CI (0.97, 1.04)
p = 0.808
2nd n = 1,961 n = 1,087 (55.4%) n = 874 (44.6%)
3rd n = 1,046 n = 569 (54.4%) n = 477 (45.6%)
4th n = 636 n = 348 (54.7%) n = 288 (45.3%)
5th n = 269 n = 152 (56.5%) n = 117 (43.5%)
6th n = 123 n = 85 (69.1%) n = 38 (30.9%)
7th n = 42 n = 27 (64.3%) n = 15 (35.7%)
8th n = 13 n = 5 (38.5%) n = 8 (61.5%)
Totals n = 7,540 n = 4,230 (56.1%) n = 3,310 (43.9%) - -
Location of cooking activities Separate kitchen room n = 624 n = 373 (59.8%) n = 251 (40.2%) p = 0.191 OR = 1 -
Elsewhere in house n = 395 n = 236 (59.7%) n = 159 (40.3%) OR 1.00
CI (0.77–1.29)
p = 0.993
-
Separate building n = 4,647 n = 2,585 (55.6%) n = 2,062 (44.4%) OR 0.84
CI (0.71–1.00)
p = 0.050
-
Outdoors n = 2,072 n = 1,157 (55.8%) n = 915 (44.2%) OR 0.85
CI (0.71–1.02)
p = 0.082
-
Other n = 8 n = 4 (50%) n = 4 (50%) OR 0.67
CI (0.17–2.71)
p = 0.578
-
Totals n = 7,746 n = 4,355 (56.2%) n = 3,391 (43.8%) - -
Cooking fuel used Electric n = 60 n = 25 (41.7%) n = 35 (58.3%) p = 0.000* OR = 1 OR = 1
Kerosene n = 1 Not enough data for analysis n = 1 Not enough data for analysis n = 1
Coal n = 1 Not enough data for analysis n = 1 Not enough data for analysis n = 1
Charcoal n = 857 n = 426 (49.7%) n = 431 (50.3%) OR 1.38
CI (0.81–2.35)
p = 0.230
OR 1.16
CI (0.67–2.00)
p = 0.601
Wood n = 6,855 n = 3,902 (56.9%) n = 2,953 (43.1%) OR 1.85
CI (1.10–3.10)
p = 0.019*
OR 1.25
CI (0.72–2.18)
p = 0.429
Straw/shrubs n = 25 n = 20 (80%) n = 5 (20%) OR 5.60
CI (1.85–16.9)
p = 0.002*
OR 3.32
CI (1.07–10.28)
p = 0.037*
Crops n = 8 n = 6 (75%) n = 2 (25%) OR 4.20
CI (0.78–22.55)
p = 0.094
OR 2.34
CI (0.43–12.75)
p = 0.327
Other n = 1 Not enough data for analysis n = 1 Not enough data for analysis n = 1
Totals n = 7,806 n = 4,380 (56.1%) n = 3,426 (43.9%) - -

*Indicates significance at the p <0.005 level

** Only the independent variables with a significant association at uni-variable analysis were included in the single multi logistic regression model.

All analytical models showed no significant relationship between sex and RARI. An independent association with RARI, adjusted multivariable logistic regression revealed children located in the central region had 18% reduced odds (OR 0.82, CI (0.72–0.93) p = 0.003) of RARI compared with the northern regions. Conversely, univariable analysis found children in the Southern region had increased odds of RARI (OR 1.18, CI (1.04–1.33) p = 0.008) compared to the northern region, however this association was not maintained when adjusted for other covariates. Rural dwelling children were also found to have significantly greater odds of RARI than urban dwellers in univariable logistic regression (OR 1.40, CI (1.21–1.62) p = 0.000) but not in multivariable models, alluding to rural dwelling not being independently associated with increased odds of RARI.

Chi squared analysis showed a significant relationship between RARI and a child’s mothers education level (p = 0.006). Further exploration of this relationship with logistic regression analysis showed that only children of mothers who had received higher education were significantly less likely to RARI with 44% reduced odds (OR 0.57. CI (0.36–0.90) p = 0.016) compared to those of mothers with no education. However, when tested against other covariates no association between mother’s education and RARI was found.

Mutlivariable logistic regression showed that children in the higher wealth quintiles had statistically significant increasingly reduced odds of RARI when compared to the poorest; middle (OR 0.86, CI (0.75–0.99) p = 0.039, fourth (OR 0.83, CI (0.71–0.96) p = 0.010, richest (OR 0.74, CI (0.61–0.89) p = 0.002). The WHO weight for height Z-score was not shown to be associated with RARI, this is not surprising as 96.2% of children scored within normal parameters. The number of people living in the house with was not associated with RARI, and neither was the number of children under 5 residing in the house, or child’s birth order (Table 2).

There was no significant association between cooking location and RARI.

However, univariable analysis found a significant association between type of cooking fuel used and RARI (p = 0.000). Logistic regression found that those utilising the most frequently used fuel type, wood, to have 85% increased odds of RARI when compared to air pollution-free electric fuel (OR 1.85, CI (1.10–3.10) p = 0.019). This significance was not maintained when inputted into multivariable logistic regression suggesting confounding variables drove this result. Even after adjusting for covariates in multiple regression, children who lived in houses who burnt shrubs/straw as fuel had statistically significant much greater odds of RARI (OR 3.32, CI (1.07–10.28) p = 0.037) when compared to electric fuels. Other fuels were not found to be significantly associated or lacked the sufficient sample size for analysis (Table 2).

PCV results

Only 2% (n = 236) of the 11,462 children aged 1–36 months did not have data on whether or not they had a vaccination card therefore we do not report non-response separately in our PCV analysis. For children who did not have a vaccination card, their caregiver verbally reported if the child had ever received the PCV and, if answered yes, how many. Results showed 10.6% of children did not have a vaccination card, 10.8% had a card but it was not shown to the investigator and 78.6% presented their card for viewing. For those that did not have a card to evidence, 94.9% reported that their child had received at least one PCV vaccine whilst 5.1% had never had a PCV vaccine. 73.0% of children without a vaccine card reported having all 3 PCV, 17.1% had received 2 and 9.8% had only received 1 (S2 Table S1 File).

For children aged 1–36 months who had vaccination cards, PCV vaccination status and year given was recorded by the interviewer. All “yes” answers from each year, 2011, 2012, 2013, 2014 were combined to give an overall indication of the number of children who had received the PCV from their vaccination cards (S3 Table S1 File).

To summarise all the children aged between 1–36 months who had received PCV vaccinations into a numerical variable, the verbally reported responses and vaccination card responses were combined to produce the new PCVtotals variable for each of the three doses to enable analysis (S3 Fig in S1 File).

PCV vaccine coverage

Using the PVCtotals variable, vaccine coverage estimates were calculated for each PCV dose for children aged 1–36 months. We estimate 93.3% of 1–36 month olds to have received PCV1, 86.8% to have received PCV2 and 77.0% to have received all 3 doses (Table 3).

Table 3. PCV coverage calculations and result estimates.

Total number of children aged 1–36 months surveyed about their PCV status % Vaccine coverage for 1–36 month olds between November 2011—April 2014
PCV1
n = combining PCV1 total sample number from record card and verbal report: 8,449 + 2,049 = 10,498 (100/10498) x 9797 = 93.3%
PCV2
n = combining PCV2 total sample number from record card and verbal report: 8,426 + 2,049 = 10,475 (100/10475)x 9,096 = 86.8%
PCV3
n = combining PCV3 total sample number from record card and verbal report: 8,362 + 2,049 = 10,411 (100/10411)x 8,016 = 77.0%

Using the PCVtotals variable we were able to compare the average age a child received each PCV dose in our sample for the years 2011/12/13/14. Results show the average age for a child to receive their first dose of PCV has declined from 30.5 months in 2011 to 2.9 months in 2014, a reduction of 26.6 months. The average age to receive the 2nd PCV dose has reduced from 30.8 to 4.4 months old, a reduction of 26.4 months and the average age of the 3rd dose also declined by 26.1 months from 31.8 to 5.7 months old (See Fig 2).

Fig 2. Demonstrating a child’s average age in months to receive PCV/1/2/3 since introduction in 2011 and survey completion in 2014.

Fig 2

No significant association was found in analysis between sex and any PCV dose (see Table 4 for all PCV1/2/3 results). When compared to the northern region, uni-variable analysis found southern dwelling children to have 16% reduced odds of receiving PCV1 (OR 0.84, CI (0.72–0.99) p = 0.035*) 22% reduced odds of PCV2 (OR 0.78, CI (0.68–0.89) p = 0.000*) and 20% reduced odds of receiving PCV3 (OR 0.80, CI (0.71–0.90) p = 0.000*). Only PCV2 maintained a statistically significant odds reduction association for southern dwellers when adjusted for confounders in multi-variable analysis (OR 0.85, CI (0.72–0.996) p = 0.044*). When comparing the central region to the north, logistic regression found children living in the central region to have reduced odds of receiving PCV2 (OR 0.85 CI (0.73–0.98) p = 0.026*) and PCV3 (OR 0.84, CI (0.75–0.96) p = 0.008*). This association was not significant in multivariable analysis and is therefore not independently associated with receiving PCV2.

Table 4. Socio-economic associations with PCV1/2/3 for 1–36 month olds.

Exposure variable PCV1 Chi Squared uni- variable analysis Chi Squared PCV1 (95% CI) Logistic regression PCV1 (95% CI) Multi variable logistic regression PVC1 (95% CI) PCV2 Chi Squared uni- variable analysis Chi Squared PCV2 (95% CI) Logistic regression PCV2 (95% CI) Multi variable logistic regression PVC2 (95% CI) PCV3 Chi Squared uni- variable analysis Chi Squared PCV3 (95% CI) Logistic regression PCV3 (95% CI) Multi variable logistic regression PVC3 (95% CI)
Yes No Yes No Yes No
Sex n = 11,287
Male n = 5,640 n = 4,920 (87.2%) n = 720 (12.8%) p = 0.172 OR = 1 - n = 4,572 (81.1%) n = 1,068 (18.9%) p = 0.202 OR = 1 - n = 4,000 (70.9%) n = 1,640 (29.1%) p = 0.819 OR = 1 -
Female n = 5,647 n = 4,877 (86.4%) n = 770 (13.6%) OR 0.93
CI (0.83–1.03)
p = 0.172
n = 4,524 (80.1%) n = 1,123 (19.9%) OR 0.94
CI (0.86–1.03)
p = 0.202
n = 4,016 (71.1%) n = 1,631 (28.9%) OR 1.01
CI (0.93–1.10)
p = 0.819
Region n = 11,287
Northern n = 1,898 n = 1,667 (87.8%) n = 231 (12.2%) p = 0.021* OR = 1 OR = 1 n = 1,581 (83.3) n = 317 (16.7%) p = 0.001* OR = 1 OR = 1 n = 1,412 (74.4%) n = 486 (25.6%) p = 0.001* OR = 1 OR = 1
Central n = 3,835 n = 3,359 (87.6%) n = 476 (12.4%) OR 0.98
CI (0.83–1.16)
p = 0.794
OR 1.12
CI (0.93–1.35)
p = 0.233
n = 3,102 (80.9%) n = 733 (19.1%) OR 0.85
CI (0.73–0.98)
p = 0.026*
OR 0.96
CI (0.81–1.14)
p = 0.645
n = 2,725 (71.1%) n = 1,110 (28.9%) OR 0.84
CI (0.75–0.96)
p = 0.008*
OR 0.97
CI (0.83–1.12)
p = 0.641
Southern n = 5,554 n = 4,771 (85.9%) n = 783 (14.1%) OR 0.84
CI (0.72–0.99)
p = 0.035*
OR 0.94
CI (0.79–1.12)
p = 0.486
n = 4,413 (79.5%) n = 1,141 (20.5%) OR 0.78
CI (0.68–0.89)
p = 0.000*
OR 0.85
CI (0.72–0.996)
p = 0.044*
n = 3,879 (69.8%) n = 1,675 (30.2%) OR 0.80
CI (0.71–0.90)
p = 0.000*
OR 0.88
CI (0.76–1.01)
p = 0.078
Area n = 11,287
Urban n = 1,263 n = 1,140 (90.3%) n = 123 (9.7%) p = 0.000* OR = 1 OR = 1 n = 1,065 (84.3%) n = 198 (15.7%) p = 0.000* OR = 1 OR = 1 n = 942 (74.6%) n = 321 (25.4%) p = 0.003* OR = 1 OR = 1
Rural n = 10.024 n = 8,657 (86.4%) n = 1,367 (13.6%) OR 0.68
CI (0.56–0.83) p = 0.000*
OR 0.76
CI (0.59–0.96) p = 0.024*
n = 8,031 (80.1%) n = 1,993 (19.9%) OR 0.75
CI (0.64–0.88) p = 0.000*
OR 0.92
CI (0.75–1.13)
p = 0.435
n = 7,074 (70.6%) n = 2,950 (29.4%) OR 0.82
CI (0.71–0.93)
p = 0.003*
OR 1.04
CI (0.87–1.25) p = 0.653
Age group n = 11,287
1–5 months n = 1,511 n = 1,016 (67.2%) n = 495 (32.8%) p = 0.000* OR = 1 OR = 1 n = 688 (44.9%) n = 833 (55.1%) p = 0.000* OR = 1 OR = 1 n = 328 (21.7%) n = 1,183 (78.3%) p = 0.000* OR = 1 OR = 1
6–11 months n = 1,791 n = 1,737 (96.9%) n = 54 (3.0%) OR 15.7
CI (11.7–21.0)
p = 0.000*
OR 15.9
CI (11.9–21.3)
p = 0.000*
n = 1,682 (93.9%) n = 109 (6.1%) OR 19.0
CI (15.2–23.6)
p = 0.000*
OR 19.4
CI (15.6–24.1)
p = 0.000*
n = 1,528 (85.3%) n = 263 (14.7%) OR 21.0
CI (17.5–25.1)
p = 0.000*
OR 21.8
CI (18.2–26.1)
p = 0.000*
12–23 months n = 3,870 n = 3,701 (95.6%) n = 169 (4.4%) OR 10.7
CI (8.8–12.9)
p = 0.000*
OR 10.9
CI (9.0–13.1)
p = 0.000*
n = 3,621 (93.6%) n = 249 (6.4%) OR 17.9
CI (15.2–21.0)
p = 0.000*
OR 18.3
CI (15.5–21.6)
p = 0.000*
n = 3,406 (88.1%) n = 464 (12.0%) OR 26.5
CI (22.6–30.9)
p = 0.000*
OR 27.5
CI (23.5–32.2)
p = 0.000*
24–35 months n = 3,795 n = 3,262 (86.0%) n = 533 (14.0%) OR 3.0
CI (2.6–3.4)
p = 0.000*
OR 3.03
CI (2.63–3.50)
p = 0.000*
n = 3,047 (80.3%) n = 748 (19.7%) OR 5.0
CI (4.4–5.7)
p = 0.000*
OR 5.08
CI (4.46–5.79)
p = 0.000*
n = 2,694 (71.0%) n = 1,101 (29.0%) OR 8.83
CI (7.66–10.2)
p = 0.000*
OR 9.09
CI (7.89–10.5)
p = 0.000*
Mothers education level n = 11,277
None n = 1,345 n = 1,134 (84.3%) n = 211 (15.7%) p = 0.002* OR = 1 OR = 1 n = 1,040 (77.3%) n = 305 (22.7%) p = 0.000* OR = 1 OR = 1 n = 886 (65.9%) n = 459 (34.1%) p = 0.000* OR = 1 OR = 1
Primary n = 7,966 n = 6,910 (86.7%) n = 1,056 (13.3%) OR 1.22
CI (1.04–1.43)
p = 0.016*
OR 1.08
CI (0.90–1.29) p = 0.435
n = 6,396 (80.3%) n = 1,570 (19.7%) OR 1.19
CI (1.04–1.37)
p = 0.012*
OR 1.06
CI (0.90–1.25) p = 0.465
n = 5,619 (70.5%) n = 2,347 (29.5%) OR 1.24
CI (1.10–1.40)
p = 0.001*
OR 1.16
CI (1.01–1.34)
p = 0.079
Secondary n = 1,845 n = 1,636 (88.7%) n = 209 (11.3%) OR 1.46
CI (1.19–1.79)
p = 0.000*
OR 1.16
CI (0.91–1.48) p = 0.240
n = 1,542 (83.6%) n = 303 (16.4%) OR 1.49
CI (1.25–1.78)
p = 0.000*
OR 1.21
CI (0.98–1.51) p = 0.082
n = 1,399 (75.8%) n = 446 (24.2%) OR 1.63
CI (1.39–1.90)
p = 0.000*
OR 1.52
CI (1.25–1.84)
p = 0.000*
Higher n = 121 n = 110 (90.9%) n = 11 (9.1%) OR 1.86
CI (0.98–3.51)
p = 0.056
OR 0.996
CI (0.48–2.05) p = 0.990
n = 110 (90.9%) n = 11 (9.1%) OR 2.93
CI (1.56–5.52)
p = 0.001*
OR 1.77
CI (0.86–3.62) p = 0.120
n = 105 (86.8%) n = 16 (13.2%) OR 3.40
CI (1.99–5.82)
p = 0.000*
OR 2.68
CI (1.43–5.04)
p = 0.002*
Wealth quintile n = 11,287
Poorest n = 2,648 n = 2,251 (85.0%) n = 379 (15.0%) p = 0.001* OR = 1 OR = 1 n = 2,060 (77.8%) n = 588 (22.2%) p = 0.000* OR = 1 OR = 1 n = 1,784 (67.4%) n = 864 (32.6%) p = 0.000* OR = 1 OR = 1
Second n = 2,469 n = 2,164 (86.7%) n = 332 (13.3%) OR 1.15
CI (0.98–1.35)
p = 0.082
OR 1.14 CI (0.96–1.36) p = 0.141 n = 1,996 (80.0%) n = 500 (20.0%) OR 1.14
CI (0.996–1.30)
p = 0.057
OR 1.13
CI (0.97–1.32)
p = 0.116
n = 1,749 (70.1%) n = 747 (29.9%) OR 1.13
CI (1.01–1.28)
p = 0.037*
OR 1.13
CI (0.98–1.30)
p = 0.083
Middle
n = 2,421
n = 2,105 (87.0%) n = 316 (13.1%) OR 1.17
CI (1.00–1.38)
p = 0.047*
OR 1.24 CI (1.03–1.48) p = 0.020* n = 1,944 (80.3%) n = 477 (19.7%) OR 1.16
CI (1.02–1.33)
p = 0.029*
OR 1.22
CI (1.04–1.43)
p = 0.015*
n = 1,718 (71.0%) n = 703 (29.0%) OR 1.18
CI (1.05–1.33)
p = 0.006*
OR 1.24
CI (1.07–1.43)
p = 0.003*
Fourth n = 2,042 n = 1,774 (86.9%) n = 268 (13.1%) OR 1.17
CI (1.00–1.38)
p = 0.047*
OR 1.13
CI (0.93–1.36)
p = 0.222
n = 1,672 (81.9%) n = 370 (18.1%) OR 1.29
CI (1.12–1.49)
p = 0.001*
OR 1.26
CI (1.07–1.50)
p = 0.007*
n = 1,488 (72.9%) n = 554 (27.1%) OR 1.30
CI (1.15–1.48)
p = 0.000*
OR 1.27
CI (1.09–1.48)
p = 0.002*
Richest
n = 1,680
n = 1,503 (89.5%) n = 177 (10.5%) OR 1.50
CI (1.24–1.81)
p = 0.000*
OR 1.35
CI (1.05–1.72)
p = 0.018*
n = 1,424 (84.8%) n = 256 (15.2%) OR 1.59
CI (1.35–1.87)
p = 0.000*
OR 1.57
CI (1.26–1.95)
p = 0.000*
n = 1,277 (76.0%) n = 403 (24.0%) OR 1.53
CI (1.34–1.76)
p = 0.000*
OR 1.54
CI (1.27–1.88)
p = 0.000*
Number of people living in house n = 11,287
< 5 n = 6,215 n = 5,419 (87.2%) n = 796 (12.8%) p = 0.133 OR = 1 - n = 5,032 (81.0%) n = 1,183 (19.0%) p = 0.478 OR = 1 - n = 4,457 (71.7%) n = 1,758 (28.3%) p = 0.158 OR = 1 -
6–10 n = 4,810 n = 4,144 (86.2) n = 666 (13.9%) OR 0.91
CI (0.82–1.02)
p = 0.111
- n = 3,857 (80.2%) n = 953 (19.8%) OR 0.95
CI (0.87–1.05)
p = 0.305
- n = 3,380 (70.3%) n = 1,430 (29.7%) OR 0.93
CI (0.86–1.01)
p = 0.097
-
11–25 n = 262 n = 234 (89.3%) n = 28 (10.7%) OR 1.23
CI (0.82–1.83)
p = 0.314
- n = 207 (79.0%) n = 55 (21.0%) OR 0.88
CI (0.65–1.20)
p = 0.430
- n = 179 (68.3%) n = 83 (31.7%) OR 0.85
CI (0.65–1.11)
p = 0.233
-
Number of children U5 living in house n = 11,287
1–3 n = 11,210 n = 9,734 (86.8%) n = 1,476 (13.2%) p = 0.195 OR = 1 n = 9,044 (80.7%) n = 2,166 (19.3%) p = 0.004* OR = 1 OR = 1 n = 7,971 (71.1%) n = 3,239 (28.9%) p = 0.015* OR = 1 OR = 1
4–6 n = 77 n = 63 (81.8%) n = 14 (18.2%) OR 0.68
CI (0.38–1.22)
p = 0.198
n = 52 (67.5%) n = 25 (32.5%) OR 0.50
CI (0.31–0.80)
p = 0.004*
OR 0.48
CI (0.27–0.84)
p = 0.010*
n = 45 (58.4%) n = 32 (41.6%) OR 0.57
CI (0.36–0.90)
p = 0.016*
OR 0.56
CI (0.33–0.96)
p = 0.035*

*Indicates significance at the p <0.005 level

** Only the independent variables with a significant association at uni variable analysis were included in the single multi logistic regression model

For all 3 doses, uni-variable logistic models found rural children to have reduced odds of receiving the PCV compared to urban children PCV1 32% (OR 0.68, CI (0.56–0.83) p = 0.000*) PCV2 25% (OR 0.75, CI (0.64–0.88) p = 0.000*) PCV3 18% (OR 0.82, CI (0.71–0.93) p = 0.003*). Only the PCV1 association was statistically significant when adjusted for confounding variables in multi-variable analysis (OR: 0.76, CI (0.59–0.96) p = 0.024).

In all models, when compared to the 1–5 month age group, all age groups had statistically significant increased odds of PCV for all doses showing it to be independently associated with RARI, however the odds decreased with increasing age (see Table 4).

In uni-variable logistic regression for PCV1, mothers with primary education had a 22% increased odds of receiving PCV1 (OR 1.22, CI (1.04–1.43) p = 0.016*) and secondary education had a 46% increased odds of receiving PCV1 (OR 1.46, CI (1.19–1.79) p = 0.000*). In uni-variable logistic regression for PCV2, mothers with primary education had a 19% increased odds of receiving PCV2 (OR 1.19, CI (1.04–1.37) p = 0.012*), secondary education revealed a 49% increased odds of receiving PCV2 (OR 1.49, CI (1.25–1.78) p = 0.000*) which increased further with a higher education (OR 2.93 CI (1.56–5.52) p = 0.001*) when compared to no education. When adjusted for covariates, these associations between PCV1, PCV2 and a mother’s education were not significant. Multi-variate logistic regression found children with mothers with a secondary (OR 1.52, CI (1.25–1.84) p = 0.000*) or higher education level (OR 2.68, CI (1.43–5.04) p = 0.002*) had statistically significant increased odds of receiving all 3 PCV doses when compared to no education.

For all 3 PCV doses, multi-variable logistic regression found children in the middle, fourth and richest wealth quintiles to have statistically significant increased odds of receiving the PCV vaccine when compared to the poorest (Table 4) making wealth independently associated with receiving all 3 PCV doses. The number of people residing in the house with the child was not found to have any statistically significant relationship with any PCV dose.

Mutli-variable logistic regression found children living with 4–6 CU5 to have decreased odds of receiving PCV2 and PCV3 when compared to children living in houses with 1–3 CU5 (PCV2 52% reduced odds (OR 0.48, CI (0.27–0.84) p = 0.010*) PCV3 44% reduced odds (OR 0.56, CI (0.33–0.96) p = 0.035*). This result makes CU5 living with 4–6 CU5 statistically significantly associated with reduced odds of receiving PCV doses (see Table 4 for all PCV1/2/3 results).

Discussion

The findings of this study are of public health importance as it is the first we know of to assocate nationally representative socio-economic factors with RARI in CU5 and PCV uptake in children aged 1–36 months in Malawi where the RARI burden is among the world’s highest. Our study also estimated vaccine coverage in 2014 for 1–36 year olds and calculated the average age a child received PCV doses in 2011/12/13/14. Our study can inform programmers on where to provide targeted interventions to improve PCV uptake or avert ARI in the country.

The strengths of the study are its large sample size and that we used publicly available UNICEF MICS data, therefore, this study could be easily repeated by others when the next survey is complete, to reliably monitor progress.

RARI

56% of children U5 in our community based sample RARI in the 2 week period prior to the survey interview. This is a very high percentage which is difficult to compare with others studies that are region specific or who utilise different measures to identify ARI or clinically diagnose pneumonia in hospitals. One such example is a cluster randomised controlled trial by Mortimer et al [32] which reports an U5 pneumonia incidence rate of 15·67 per 100 child-years. A Malawi based study by Cox et al [6] estimated 2014’s annual pneumonia prevalence for U5’s at 32.6% (95% CI 29.3%- 36.0%), much below our estimations. These studies cannot be compared as Cox et al [6] collected data from the hospital health passports of 91.2% of their sample and true cases of pneumonia were diagnosed by health professionals, excluding cases of ARI, whereas in our study we categorised by ARI at house hold level.

Survey data has been found to produce over estimates which may explain why our retrospective 2 week prevalence percentage is so high. In this survey, RARI was identified on the basis of caregivers reporting 2 symptomatic indicators; a cough and fast or difficulty in breathing, which were not clearly defined or quantified, potentially causing high levels of measurement bias. Interviewers relied on the inherent limited ability of caregivers to correctly recognise and RARI. Prevalence estimates from this survey should be interpreted with caution as they are based on caregivers perception of symptoms and their capacity to recall events up to 2 weeks later, which may be prone to recall bias. Another consideration is that the ARI indicator does not record severity of symptoms or illness specificity, e.g. whether symptoms are due to asthma, infection or pneumonia or whether symptoms just need antibiotics or are life threatening. Acknowledging this, the MICS refers to ARI rather than pneumonia and this is why pneumonia estimates composed from survey data, such as the MICS, are thought to greatly inflate the number of pneumonia cases with most reported episodes being false positives [33].

Despite the flaws of RARI and assumed over estimation of pneumonia cases in survey data, the RARI indicator in MICS surveys is still deemed valid as it is a quick and simple measure applicable in the field [33]. Given the prevalence and high mortality rates from pneumonia, there is an urgent need for research to measure the sensitivity and specificity of RARI for the identification of true pneumonia cases. It has been proposed that it is possible to increase test specificity without negatively impacting the study design by adding a few additional symptoms or signs to survey questionnaires and employing a “pneumonia score” [34]. An evaluation of this measure is yet to be validated.

Our study found independent associations with reduced RARI to be central region living and children in the middle/fourth and richest wealth quintiles. Using straw/shrubs as fuel was found to be independently associated with increased RARI odds. Children living in the central region had reduced odds of RARI when compared to the north (OR 0.82, CI (0.71–0.93) p = 0.003). As there has been no nationally representative statistical analysis comparing regions associated with RARI or true pneumonia, we do not have any results to compare ours to. Our results suggest that further investigation is needed to examine reasons for regional discrepancies in RARI.

Our finding that using straw/shrubs as a cooking fuel increased the odds of RARI owing to poor air quality are not supported by a Malawian cluster RCT with an intervention of introducing a biomass stove by Mortimer et al [32]. The unexpected non-significant findings by Mortimer et al [32] were explained by exposure from other sources of air pollution such as rubbish burning and tobacco smoke, a potential confounder this study also could not account for. Despite this, our findings present evidence to deter families from burning straw/shrubs as it increases their odds of RARI.

Although not independently associated with RARI, that rural dwellers had increased odds of RARI in univariable analysis was not surprising when accounting for 95% of the poorest in Malawian living rurally [35] and our adjusted results demonstrating decreased odds of RARI for those in the highest wealth quintiles compared to the lowest. Conditions of poverty such as poor sanitation, lack of clean water and irregular hand washing cause a greater risk of pneumonia [36].

We found no association between RARI and sex, in difference with Cox et al [6] who reported that males are more likely to be affected. However, in Cox et al [6] cross-sectional study the male sample size was much larger than the female, the RARI sample cases small (n = 69) and the data was not weighted in analysis, which may explain this unexpected result.

No age group was found to have greater odds of RARI, however other studies have found higher ARI rates in children aged 6–23 months [7]. This difference is hard to compare as the study designs differed greatly. McCollum et al [7] conducted active pneumonia surveillance and actual pneumonia cases were diagnosed by clinicians, thus likely producing far more precise results than the generalised MICS data.

Our isolated, statistically significant, univariable logistic regression finding that children whose mother’s attained a higher education had reduced odds of RARI is likely due to chance. A statistically significant p value of p <0.05 still allows for 1 in 20 effects to be due to chance [31].

That cooking location was not significantly associated with RARI was unsurprising considering most of the sample cooked in a separate kitchen or outdoors, thus reducing air pollution which has been evidenced to cause pneumonia [37]. A major limitation of the survey is that it doesn’t account for significant confounding comorbidities that predispose some children to pneumonia more than others, such as HIV [38]. Additionally, household surveys only include families with a permanent residence and can exclude those most vulnerable with less access to health care such as the homeless, displaced, children living in orphanages and nomadic families [39], thus possibly introducing selection bias.

PCV

Our study found age group and wealth to be independent associated with 1–36 month olds receiving all 3 PCV doses. Secondary and higher educational attainment of mothers was independently associated with receiving 3 PCV doses only. Children living with 4–6 other children were found to independently have reduced odds of receiving PCV doses 2 and 3.

The advantages of using data from surveys such as the MICS is that that they are nationally representative, have large sample sizes, are of no cost to use and the instant obtainment of data via a download is very time effective. In LIC such as Malawi that lack accurate records, vaccine data often comes from caregiver interviews which risks recall and social biases. A strength of MICS surveys is that they collate information from vaccination cards and verbal recall when vaccination cards are not available so that there are no gaps in the data.

Positively, our results show the average age for a child to receive PCV1/2/3 has reduced by an average of 26.6 / 26.4 and 26.1 months, likely due to effective vaccine catch up campaigns. This study estimated 93.3% of 1–36 month olds to have received PCV1, 86.8% to have received PCV2 and 77.0% to have received all 3 doses. These findings are similar to the MICS [24] report of the same data set, but with some differences due to the MICS report separating estimates into age categories whereas this study averages 1–36 month olds. Another reason for the slight difference is that this studies estimates included recall data, whereas the MICS [24] report assumed that “For children without vaccination cards, the proportion of vaccinations given before the first birthday is assumed to be the same as for children with vaccination cards”.

This study found 21% of children in our sample did not have a vaccination card or did not show it to the interviewer, however nearly 95% of these caregivers reported their children as having had at least one PCV. 21% is a large proportion of the sample, and therefore the opportunity for bias to reduce data accuracy is significant.

Although not a Malawian study or for the PCV, in Guatemala Goldman and Pebley [40] found that DTP coverage rates were similar for those with vaccine cards (70%) and those with cards but who were unable to present them (66.9%) whilst coverage estimates based on data acquired from recall was much less at 48.5%. Although actual causation cannot be provided, these results were suggested to be accurate as they probably reflect reality, in that the absence of a vaccine card may be an indicator of infrequent contact with health care and therefore explains the lower vaccine coverage.

With no valid method for handling incomplete data and ensuring reliability of recall data, a systematic review of caregiver recall as a measure of vaccine coverage by Modi et al [41] concluded that recall data should be included to exclude bias and called for further research on increasing recall quality. A strength of our study is that it included recall data in PCV coverage estimates, in keeping with advice from existing research, potentially making our estimates more generalisable to the Malawian population and more accurate.

Although great improvements have been made, our results and other existing evidence shows that by April 2014, PCV coverage did not meet the Malawi Ministry of Health three-dose coverage target of 90% before 12 months. Our nationally representative study of children aged 1–36 months estimated that 77.0% of children had received all 3 PCV doses, less than the 86.0% estimated by Bondo et al [13], in rural children only, in one area (Kabadula) of one district (Lilongwe) of Malawi, aged between 6 weeks and 16 months. This could be explained by this studies findings in univariable logistic regression analysis that rural children have 0.82 reduced odds of receiving all 3 PCV vaccinations when compared to urban (p = 0.003, CI 0.71–0.93, however in multivariable regression there was no difference found, perhaps because of confounding of rural dwelling with other explanatory variables e.g. lower education, lower wealth quintile. That rural children were found to have decreased odds of PCV vaccination in univariable analysis is unsurprising and has previously been explained by longer distances to travel for health services [16].

The impact of our greatly reduced average age of vaccination between 2011 and 2014 is significant, as delayed vaccination extends susceptibility to ARI and reduces herd immunity [42]. Another positive confirmation from our results is that no association between sex and vaccination status was found, demonstrating that in Malawi one sex does not receive more favourable access to vaccinations.

Additionally, in multi-variable logistic analysis region was also found not to be associated with PCV vaccination, demonstrating the access to PCV vaccines is comparable across regions. An earlier study by Abebe et al [20] disagrees with this finding and found the northern region of Malawi to have lower vaccination rates. However, this study was based on data from 2007, before the PCV vaccine was introduced and optimistically, vaccine services may have been scaled up since then to produce our result. Regional differences often exist due to inequalities in health worker density and service provision [43]. Our finding of no significant regional difference is important as regional inequality of vaccine coverage can harbour clusters of under-vaccinated children, leading to an increased vulnerability of vaccine-preventable diseases such as pneumonia [20].

Given the vaccination catch up campaigns for those under 12 months and the advised vaccine delivery doses at 6,10 and 14 weeks for PCV/2/3 respectively, it is unsurprising that children older than 6 months were found to have increased odds of PCV uptake for all doses in all statistical tests with the highest uptake in the 6–11 month age category. Mvula et al [17], had similar findings as did McCollum et al [7] who found children aged 6–23 months old had the highest proportion of all 3 doses (71.7%, n = 8,567/11,948). This result is a promising find as it suggests greater vaccination coverage for children under 5 in the future and targets protecting children aged under 2 years old who are disproportionally affected by ARI with 80% of deaths attributed to ARI in this age group [44].

Once adjusted for confounding co-variables, only mothers with secondary or higher education had increased odds of a child receiving all 3 PCV does when compared to those with no education. This finding emphasises the importance of maternal education on a child’s health. It is thought educated women have great autonomy and control over household resources enhancing care seeking behaviours and their ability to comprehend health needs [45].

Across all doses, wealth greater than the 2 poorest quintiles was found to be associated with greater PCV uptake. This result is supported in the literature by Austin et al [18], and Zere et al [19], who reasoned that the poorest in society have less access to public health services with more barriers to health care such as accessing transport than wealthier parents.

Children living in houses with 4–6 children under 5 were found to have reduced odds of receiving PCV2 and PCV3 vaccine doses compared to those living in houses with 1–3 children under 5. A practical explanation for this could be that with so many other young children to care for, time resources are restricted which results in de-prioritising taking your child to be vaccinated. Dahiru [31] suggested that quantitative evidence cannot give us all the answers, and therefore we should always seek non-statistical evidence such as frequency distributions, theory and qualitative evidence wherever available to compare findings and fill the gaps. We suggest that qualitative research is needed to understand the reasons why some children are not vaccinated. Future research could also compare the next MICS survey with the 2015 one used in this study to look for trends. Additionally, the MICS and DHS data could be combined to increase sample size and generalisability, though care would be needed to ensure survey questions and methods are sufficiently equivalent.

Conclusion

To achieve SDG targets and reduce preventable deaths of children under 5, it is essential Malawi addresses the high RARI burden. Whilst acknowledging the limitations of using survey data and the potential for recall bias, our cross-sectional analysis of secondary data reported social economic associations with RARI in children under 5 and PCV vaccine uptake for children aged 1–36 months. Our study estimated PCV vaccine coverage estimates for 2014 that were found to be below the >90% target but found significant decreases in average age a child received all 3 PCV vaccine doses since its introduction in 2011. Our findings highlight the importance of a mother’s education on her child’s health, the association between poverty and child health and recommends that straw/shrubs not be used as fuel.

Future studies are needed to validate a survey pneumonia specificity and sensitivity test that differentiates it from RARI. Qualitative research would aid understanding of the reasons children aren’t vaccinated.

Supporting information

S1 File

(DOCX)

S1 Data

(DO)

S1 Dataset

(DTA)

Abbreviations

ARI

Acute respiratory illness

children, CU5

Children under 5

CI

Confidence intervals

MICS

Multiple Indicator Cluster Survey

ORs

Odds ratios

PCV

Pneumococcal conjugate vaccine

RARI

Reported acute respiratory infections

SDG

Sustainable Development Goal

SEAs

Sample enumeration areas

WHO

World Health Organisation

Data Availability

We used data from the 2014 UNICEF Malawi Multiple Indicator Cluster Survey (https://mics.unicef.org/surveys), which is freely available online. From this we created a minimal data set which we include in the Supporting information files. We also include, as Supporting information, Stata code used to create the minimal data set from the MICS 2014 datasets and reproduce the analyses in the paper.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.UNICEF. 2019. One child dies of pneumonia every 39 seconds, agencies warn. Accessed 13/05/21. https://www.unicef.org/press-releases/one-child-dies-pneumonia-every-39-seconds-agencies-warn
  • 2.Save the Children, 2017. Fighting for breath: a call to action on childhood RARI. Save the Children. Accessed on 11/12/19. https://www.savethechildren.org.uk/content/dam/global/reports/health-and-nutrition/fighting-for-breath-low-res.pdf
  • 3.Divala O., Michelo C. and Ngwira B. 2014. Morbidity and mortality in HIV‐exposed under‐five children in a rural Malawi setting: a cohort study. J Int AIDS Soc, 14 (Suppl 3). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.National Statistical Office (NSO), ICF Macro. Malawi Demographic and Health Survey 2010. Zomba, Malawi, and Calverton, Maryland, USA: NSO and ICF Macro, 2011.
  • 5.Lazzerini M., Seward N., Lufesi N., Banda R., Sinyeka S., Masache G., et al. 2016. Mortality and its risk factors in Malawian children admitted to hospital with clinical pneumonia, 2001–12: a retrospective observational study panel. The Lancet Global Health. 4 (1), pp. e57–e68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cox M., Rose L., Kulua K., De Wildt G., Bailey R. and Hart J. 2017. The prevalence and risk factors for acute respiratory infections in children aged 0‐59 months in rural Malawi: A cross‐sectional study. Influenza Other Respir Viruses. 11, (6), pp. 489–496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.McCollum E.D., Nambiar B., Delua R, et al. 2017. Impact of the 13‐Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood RARI over Three Years in Central Malawi: an Observational Study. PLOS ONE 12(1): e0168209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Watkins. K. and Sridhar. D. (2018). Pneumonia: a global cause without champions. Lancet, 392, (10149), pp. 718–719. doi: 10.1016/S0140-6736(18)31666-0 [DOI] [PubMed] [Google Scholar]
  • 9.Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. The Pediatric Infectious Disease Journal, (3), pp. 187–95. [DOI] [PubMed] [Google Scholar]
  • 10.Heinsbroek E., Tafatatha T., Phiri. A., Swarthout T.D., Alaerts M., Crapin A.C., et al. 2018. Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination. Vaccine. 36 (48). pp. 7369–7376. doi: 10.1016/j.vaccine.2018.10.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.WHO. 2007. Weekly Epidemiological Record. 82, (12). pp 93–104.
  • 12.WHO. 2011. Global Immunization News. https://www.who.int/immunization/GIN_November_2011.pdf
  • 13.Bondo A., Nambiar B., Lufesi N., Deula R., King C., Masache G. et al. 2018. An assessment of PCV13 vaccine coverage using a repeated cross-sectional household survey in Malawi. Gates open research, 2, (37). doi: 10.12688/gatesopenres.12837.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.National Statistical Office (NSO) [Malawi], ICF. Malawi Demographic and Health Survey 2015–16. Zomba, Malawi, and Rockville, Maryland, USA: NSO and ICF, 2017.
  • 15.Malawi Ministry of Health. 2012. Expanded Programme on Immunisation Comprehensive EPI Multi-Year Plan 2012–2016 Malawi. Accessed on 11/12/19. http://www.nationalplanningcycles.org/sites/default/files/country_docs/Malawi/document_no.pdf
  • 16.Munthali A.C. 2007. Determinants of Vaccination Coverage in Malawi: Evidence FromThe Demographic And Health Survey. Malawi Med J. (2), pp. 79–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Mvula H., Heinsbroek E., Chihana M., Crampin A.C., Kabuluzi S., Chirwa G., et al. 2016. Predictors of Uptake and Timeliness of Newly Introduced Pneumococcal and Rotavirus Vaccines, and of Measles Vaccine in Rural Malawi: A Population Cohort Study. PLOS ONE | doi: 10.1371/journal.pone.0154997 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Austin P., Ntenda M., Kun-Yang C., Tiruneh F.N. and Ying-Chih C., 2017. Analysis of the effects of individual and community level factors on childhood immunization in Malawi. Vaccine, 35, pp. 1907–1917. doi: 10.1016/j.vaccine.2017.02.036 [DOI] [PubMed] [Google Scholar]
  • 19.Zere E., Moeti M., Kirigia J., Mwase T. and Kataika E. 2007. Equity in health and healthcare in Malawi: analysis of trends. BMC Publ Health. 7, pp 7–78. doi: 10.1186/1471-2458-7-78 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Abebe D.S., Nielsen V.O., and Finnvold J.E. 2012. Regional inequality and vaccine uptake: a multilevel analysis of the 2007 Welfare Monitoring Survey in Malawi. 2012. BMC Public Health, 12, Article number: 1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Pio. A. 2003. Standard case management of RARI in children in developing countries: the cornerstone of the acute respiratory infection programme. Bulletin of the World Health Organization. 81 (4), pp. 298–300. [PMC free article] [PubMed] [Google Scholar]
  • 22.UNICEF. 2016. One is too many. Ending child deaths from pneumonia and diarrhoea. UNICEF, New York.
  • 23.Shi T., McLean K.., Campbell H. amd Nair H. 2015. Etiological role of common respiratory viruses in acute lower respiratory infections in children under five years: A systematic review and meta–analysis. J Glob Health. 5 (1): 010408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.MICS 2013–14 Malawi. 2015. Accessed on 11/12/19. https://mics.unicef.org/news_entries/13
  • 25.StataCorp. 2019. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC.
  • 26.WHO. 2006. Multicentre Growth Reference Study Group. WHO child growth standards: methods and development Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age. Accessed 11/12/19. https://www.who.int/childgrowth/standards/technical_report/en/
  • 27.Filmer D., Lant H. and Pritchett L. 2001. Estimating Wealth Effects without Expenditure Data-or Tears: An Application to Educational Enrolments in States of India. Demography Demography, 38 (1). pp. 115–132. [DOI] [PubMed] [Google Scholar]
  • 28.Sharpe D. (2015). Your Chi-Square Test is Statistically Significant: Now What? Practical Assessment. Research & Evaluation. 20 (8). [Google Scholar]
  • 29.Christiansen C., Wuttidittachotti P., Prakancharoen S., and Vallipakorn A. 2015. Prediction of risk factors of software development project by using multiple logistic regression. Journal of Engineering and Applied Sciences,10 (3). [Google Scholar]
  • 30.Kim J. and Bang H. 2016. Three common misuses of P values. Dent Hypotheses. 7, (3). pp. 73–80. doi: 10.4103/2155-8213.190481 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Dahiru T. and Ib A. 2008. P–Value, A true test of statistical significance? A cautionary note. Post grad Med. 6 (1), 21–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mortimer K., Chifundo B.M., Malava D.J., Katundu C., Weston W., Havens D., et al. 2017. A cleaner burning biomass-fuelled cookstove intervention to prevent RARI in children under 5 years old in rural Malawi (the Cooking and pneumonia Study): a cluster randomised controlled trial. Lancet. 389 (10065), pp. 167–175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Campbell H., Biloglav Z., Rudan I. 2008. Reducing bias from test misclassification in burden of disease studies: use of test to actual positive ratio—new test parameter. Croat Med J, 49, pp. 402–414. doi: 10.3325/cmj.2008.3.402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hazir T., Bequem K., El Arifeen S., Khan A.M., Huque M.H., et al. 2013. Measuring coverage in MNCH: A prospective validation study in Pakistan and Bangladesh on measuring correct treatment of childhood pneumonia. PLoS Med 10, (5). doi: 10.1371/journal.pmed.1001422 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.World Bank. (2018). Malawi Systematic Country Diagnostic: Breaking the Cycle of Low Growth and Slow Poverty Reduction. Accessed 11/12/19. http://documents.worldbank.org/curated/en/723781545072859945/Breaking-the-Cycle-of-Low-Growth-and-Slow-Poverty-Reduction
  • 36.Chopra M., Mason e., Borrazzo J., Campbell H., Rudan I., Liu L., et al. 2013. Ending of preventable deaths from pneumonia and diarrhoea: an achievable goal. Lancet. 381 (9876), pp. 1499–1506. doi: 10.1016/S0140-6736(13)60319-0 [DOI] [PubMed] [Google Scholar]
  • 37.WHO. 2014. Indoor air quality guidelines: household fuel combustion. Accessed 11/12/19. http://apps.who.int/iris/bitstream/10665/141496/1/9789241548885_eng.pdf [PubMed]
  • 38.Graham S.M., Mankhambo L. Phiri A., Kaunda S., Chilkaonda T., Mukaka M., Molyneux E.M., et al. 2011. Impact of human immunodeficiency virus infection on the etiology and outcome of severe pneumonia in Malawian children. Pediatr Infect Dis J. 30 (1). pp. 33–8. doi: 10.1097/INF.0b013e3181fcabe4 [DOI] [PubMed] [Google Scholar]
  • 39.Carr-Hill R. 2012. Missing Millions and Measuring Progress towards the Millennium Development Goals with a focus on Central Asia States. Cent Asian J Glob Health. 1 (1): 24. doi: 10.5195/cajgh.2012.24 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Goldman N., Pebley A.R. 1994. Health cards, maternal reports and the measurement of immunization coverage: the example of Guatemala. Soc Sci Med, 38 (8). pp. 1075–1089. doi: 10.1016/0277-9536(94)90225-9 [DOI] [PubMed] [Google Scholar]
  • 41.Modi R.n., King C., Naor B.Z. and Colbourn T. 2018. Caregiver recall in childhood vaccination surveys: Systematic review of recall quality and use in low- and middle-income settings. Vaccine, 36, (29). pp. 4161–4170. doi: 10.1016/j.vaccine.2018.05.089 [DOI] [PubMed] [Google Scholar]
  • 42.Loo J.D., Conklin L., Fleming-Dutra K.E., Knoll M.D., Park D.E., Kirk J., et al. 2014. Pediatr Infect Dis J. 33 Suppl (2): pp. 161–171. [Google Scholar]
  • 43.Munga M.A. and Mæstad O. 2009. Measuring inequalities in the distribution of health workers: the case of Tanzania. Hum Resour Heal. 7, pp. 4–10. doi: 10.1186/1478-4491-7-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.WHO. 2015. WHO and Maternal and Child Epidemiology Estimation Group (MCEE) estimates 2015. Accessed 11/12/19. https://www.unicef.org/publications/index_93020.html
  • 45.Adhikari R. 2016. Effect of Women’s autonomy on maternal health service utilization in Nepal: a cross sectional study. BMC Womens Health, 16, Article number: 26. doi: 10.1186/s12905-016-0305-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Shinya Tsuzuki

7 Jun 2022

PONE-D-21-21665What predicts reported acute respiratory infection in children under 5 and PCV vaccination in children aged 1-36 months in Malawi? A secondary data analysis using the Malawi 2014 MICS surveyPLOS ONE

Dear Dr. Colbourn,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by July 21, 2022. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Shinya Tsuzuki, MD, MSc

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide further information in the data availability statement regarding the source of the 2014 UNICEF Malawi MICS data (for example, where the data were obtained and if any permission was required to use) as per our data availability policy (https://journals.plos.org/plosone/s/data-availability#loc-acceptable-data-access-restrictions).

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

4. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option.

Additional Editor Comments (if provided):

Both reviewers made some useful comments then please respond each of them appropriately.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Major comments

1. The manuscript seems to contain more than two separate research questions, or not conceptually connected to each other. As shown in the Title - “What predicts reported acute respiratory infection in children under 5” and PCV vaccination in children aged 1-36 months in Malawi, though the data source is the same, have separate objective, and also separately analyzed and discussed. Thus, the manuscript has too much information and difficult to follow/understand

2. Authors indicated nearly 60% non-response on RARI (In the result section). With such a huge non-response rate, the validity of the research finding, and hence the conclusion of the RARI and also the national representativeness of the research is highly questioned.

General comments

It is difficult to comment the manuscript at its current stage, as the manuscript contains chunk of information. But, generally the authors need to consider

1. The introduction section contains too much information which is not relevant for the paper/ lacks focusing on the objective. In addition, it has issues related with consistency/flow of information. The problem is not clear. Argument starts around “full vaccination” and “PCV’ going down the line.

3. Objective: Not usual to have four objectives (two primary and two secondary/specific) in scientific research papers. Hypotheses/ null hypothesis not clearly linked with the objectives

4. Methods: Too much explanation on the method used by UNICEF (MICS). Only the analysis section is inherent to this paper.

5. Results: The finding that, Over 56% of caregivers RARI in their children in the 2-week interview recall period, is very exaggerated because only the caregivers who respond to the question were included in the denominator.

The discussion and conclusion need to be reviewed based on the above, if the authors accept the comments.

Reviewer #2: The manuscript is of public health importance and was well written. However, major revisions have been suggested as regards study methods, analytic approach, results presentation and interpretations for consideration.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Ezekiel Mupere MBChB, MMed, MS., PhD

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PLOS ONE Review ARI MICs PCV Vax Malawi 06JUne2022.pdf

Decision Letter 1

Shinya Tsuzuki

10 Nov 2022

PONE-D-21-21665R1What predicts reported acute respiratory infection in children under 5 and PCV vaccination in children aged 1-36 months in Malawi? A secondary data analysis using the Malawi 2014 MICS surveyPLOS ONE

Dear Dr. Colbourn,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 25 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Shinya Tsuzuki, MD, MSc

Academic Editor

PLOS ONE

Additional Editor Comments:

Two reviewers raised further concerns and I agree with their opinion, then therefore I believe another round for revision would be appropriate for the manuscript.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #3: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #3: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear authors/ editors

Thank you again for the opportunity to review the manuscript entitled "What predicts reported acute respiratory infection in children under 5 and PCV vaccination in children aged 1-36 months in Malawi? A secondary data analysis using the Malawi 2014 MICS survey"

I appreciate the authors for the improvements they made in the manuscript, particularly in the introduction section. Though, some editorial revisions are still needed. For instance,

• Fig 3 is presented while Fig 1 and 2 are not available

• Zero missing values in table 1 are not important,

• Ethical clearance is included under the data collection section, should be separated,

• The selection of independent variables was referenced to (see introduction), but the introduction didn’t adequately address it.

• Univariate analysis table shall be presented and discussed separately before the multivariate Table should

• The numbers for the tables and figures are not correct and shall be edited

Major comments

I would like to re-emphasize on the previous comments, based on the authors response and in line with the developments in the manuscript

1. For the comment of having four objectives (two primary and two secondary/specific) and Hypotheses/ null hypothesis not clearly linked with the objectives, the authors respond that they do not see a scientific problem here and would like to keep all 4 objectives, and the hypotheses are clearly linked to our two primary objectives.

I agree that no problem of having more than one research question in a scientific paper. My intention is, for you to consider including very specific objectives under one or two comprehensive objectives, as the objectives are very similar. This would help to focus your discussion and presentation and also ease for readers.

Otherwise, authors shall consider addressing the statement of the problem and methods for each objective; and present and discuss each objective separately.

2.Methods section: Too much explanation on the method used by UNICEF (MICS). Only the analysis section is inherent to this paper.

Authors response: We believe the explanation of the methods used by UNICEF (MICS) that we have briefly summarized in this paper are relevant to readers understanding of the data we used and would like to keep this information in the paper.

Comment: I agree, but while a brief summary of the methods used by MICS is important, the methods used to for this secondary data study is more important for readers. It is important to inform readers, the design, how and what data has been extracted and organized, the operational definition, inclusion and exclusion criteria, etc., for the four objectives.

For instance the study population for RARI are U5C and for PCV coverage 1-36 months children are not the same and so is for data analysis etc., Thus, the authors shall address the methods (all subsections) used for each objective, as well as how the predictors of RARI and PCV uptake are selected

Results: The finding that, Over 56% of caregivers RARI in their children in the 2-week interview recall period, is very exaggerated because only the caregivers who respond to the question was included in the denominator.

Authors response: Thanks for highlighting this. We recognize that caregiver response to the

question on RARI in the previous two-weeks may be subject to some selection bias and this is already included as a limitation of our paper, as explained in the second paragraph of the RARI sub-section in our Discussion:

The previous comment is that the overestimation is created because the authors removed the participants who did not respond from the denominator, not due to selection bias or limitations inherent to survey methods.

The MICS 2014 reports 7.8% (~1475 of the 18981 children) with RARI (cough and fast/difficult breathing) were reported and that there was no non-response. Thus, how this study faced such a huge non-response rate, while using the same data? shall be explained and justified.

In addition, in such huge nonresponse rate, it is important to analyze the non-responses against the independent variables and explain to readers the characteristics of those who are missing and how it may affect the result.

PCV: Similar to RARI, the number/percent of children 1-36 months enrolled in PCV up take, and non-response rate should be also presented before going to the analysis.

PCV 3 coverage: The nationally representative study of children aged 1-36 months estimated that 77.0% of children had received all 3 PCV doses, less than the 86.0% estimated by Bondo et al., (2018) (PP 50). ?? Are the less than 3-month children expected to complete PCV 3 and included in the denominator? -

Reviewer #3: The manuscript by Gosling et al. reports the results of a study conducted to identify the predictors of RARI in children under 5 and the predictors of PCV in children aged 1-36 months in Malawi.

The topic of the study is important and interesting, however, the objective of the study, the statistical models and the outcome definitions are poorly described and require additional elaboration.

In general, the topic of the study is important and interesting, however, the manuscript is difficult to read and there are some methodological issues to deal with. All the following comments do not exclude that the results of the analysis are correct and interesting, but represent suggestions to improve the paper and mostly his presentation.

In particular:

• Abstract: Authors should report the objectives of the study in the abstract.

• Objectives:

o The definition of the study aims need to be revised. In particular, authors reported: “1.The national, social economic predictors for RARI in children under 5; 2. The national, social economic predictors of PCV uptake in children aged 1-36 months. The 1-36 month age range reflects the available data from the MICS survey.” I suggest to delete this last sentence (The 1-36 month age range reflects the available data from the MICS survey.) and to put it in the methods paragraph.

o For what concern the secondary objectives, they are not really objectives but results that could be reported in the results paragraph as part of the sample description.

• Methods:

o Could authors explain why they decided to consider children age as a predictor of PCV? I think that is difficult to interpret these results also because the dose of PCV (PCV1, PCV2, PCV3) depends on child age.

o About the analysis of the data, I suggest to consider the possibility of putting together some variables categories that have not enough numerosity. For example, for mother education, authors could consider secondary and higher together; for number of people residing in house they can consider 11+ as a category; child’s birth order could be considered as linear and cooking fuel used could be recategorized. I this way the results would be more clears and stable.

o In the data analysis paragraph, authors reported explanation about the chi squared test, the logistic regression and the p-value: “A chi Squared analysis is appropriate for categorical data to statistically analyse frequency distribution (Sharpe 2015).”; “Logistic regression analysis predicts the ratio of the odds of an event occurring, given the value of an independent variable compared to the reference category of the independent variable, e.g. the odds of RARI if rural living compared to urban living. Multiple logistic regression models examine the impact of multiple variables accounting for several potentially confounding variables simultaneously and is the appropriate regression analysis when the dependent variable is binary (Christiansen et al, 2015) as in this instance.” “A p value quantifies the significance of an association and the 95% CI quantifies the preciseness of the estimation with a values range (Kim and Bang, 2016) for which if the study was repeated multiple times, the true effect would be within this range 95% of the time (Dahiru 2008).” I think that is not necessary to explain them in a scientific paper, what they should reported is how they use these methods, which are the dependent and independent variables, as they done in the previous paragraphs.

o In the same way I suggest to delete the paragraphs related to hypotheses and null hypotheses, they are unnecessary if you have well described the objectives of your paper.

• Results:

o Tables 2 and 6 are very difficult to read; if authors believe that is important to show all results and all steps of the analysis, I suggest to report a table with chi squared test with all variables and a table with the complete model, reporting crude and udjusted OR of the logistic regression analysis. Otherwise, I suggest to put the information about all tested variables that resulted not associated, only in the text or in additional material.

o In the results paragraph (at page 36), authors reported: “In all models, when compared to the 1-5 month age group, all age groups had statistically significant increased odds of PCV for all doses showing it to be an independent predictor of RARI, however the odds decreased with increasing age”. Is not expected that the risk of being vaccinated increase with increasing age? Why authors do not analyze the risk of being vaccinated to PCV regardless to the number of doses?

o I have some concern about the region (northern, central and southern) and the area (urban or rural); There are urban and rural areas in all regions or these variables are showing the same things?

o In this paper authors took into account several predictors of RARI and PCV, some of these seem to represent similar aspects. Did authors evaluate collinearity or effect modification before establishing if these variables could be or not predictors of the outcomes?

MINOR COMMENTS:

• Tables titles need to be revised; for example, title of table 1 could be “Sample characteristics”; for table 2 (but also for others similar tables) I suggest to report something like “Socio economic predictors for RARI in children under 5 - results from the logistic regression model”.

• I do not understand as authors numbered figures in the paper. Figures 3 is the first figure of the paper, table 5 is after table 2.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Atakelti A Derbew

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Revision.docx

Decision Letter 2

Shinya Tsuzuki

30 Jan 2023

PONE-D-21-21665R2What predicts reported acute respiratory infection in children under 5 and PCV vaccination in children aged 1-36 months in Malawi? A secondary data analysis using the Malawi 2014 MICS surveyPLOS ONE

Dear Dr. Colbourn,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Please submit your revised manuscript by Mar 16 2023 11:59PM If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Shinya Tsuzuki, MD, MSc

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Unfortunately original reviewers had already faded away, but new reviewers added several comments based on the original review. I think their suggestions are also reasonable, then minor revision will be required.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #4: All comments have been addressed

Reviewer #5: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #4: Yes

Reviewer #5: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #4: Yes

Reviewer #5: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #4: Yes

Reviewer #5: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #4: No

Reviewer #5: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #4: I can see that the manuscript have already gone through a multiple round of review. I still have few suggestions and doubts which as follows:

What is MICS data. Author need to give full form and explain the type of mics survey and data.Why they did not use complete DHS survey?

The ethical statement should be that Author have used secondary data available in public domain and does not require ethical approval. Currently ethical statement is confusing and funding statement should also be separate.

It seems like the sections can be made little concise for example: Author does not need to state every stats from the table, they should provide important details which is important and they want to highlight. Stating wealth index or some region is x percentage does not add value it make it more verbose.

As a reader, Some one would get lost in so many obvious percentages reported for example: the wealth index should be around 20 percent because the way it gets divided into quintiles. What are the regions and why it is important?

Fig 1: the Percentages in each group with symptoms will be more useful rather than providing numbers

Why the need of chi-square test when author are performing the logistic regression. Are they used it for selecting variable.

The results section is too verbose, it need to be more focused and provide answer to the objective and research question raised in the introduction

Limitation and strength will come at the end of discussion.

Conclusion: it is not surprising to found education and wealth to be related with child health. What more the analysis add in the context of malawi or what factors brought changes in children health in Malawi? will be more useful to conclude rather than giving a generic conclusion

Reviewer #5: This paper used 2014 UNICEF Malawi Multiple Cluster Indicator Survey to analyse socio economic predictors for RARI un CU% and PCV uptake in children aged 1-36 months. I hope the authors find the following comments and suggestions helpful.

Major comments:

1. I would advise that the authors use the term "association" instead of "predictor" in the title and throughout the study, as "predictor" may mislead readers about the nature of the research conducted. In certain instances, the term "predictor" indicates to certain readers that causal analysis is performed. But in this paper's study, "endogeneity" is obviously overlooked. Therefore, it is more suitable to avoid the term "predictor" and instead use "association" in this context.

2. I would present a missing analysis, do a sensitivity analysis using imputed values for missing data, and report on how the analysis altered (if any) as a result.

3. Clearly the PCV uptake impacts the RARI in children. Thus, in Table 2 I would add the PCV uptake variable as an independent variable in the analysis. Otherwise this will create omitted variable bias.

4. The price type of the fuel used for cooking might be used as an indication of socioeconomic class. I would advise grouping them as expensive, moderately priced, and inexpensive cooking fuels and using that variable instead of the actual cooking fuel (electricity, coal, wood etc) used.

5. In PCV analysis it would be great and much more useful if a bivariate constabulary analysis of PCV uptake and socioeconomic indicators are reported.

6. The discussion part might be enhanced by arguing in accordance with the policy context and comparing the findings to those of other nations. This would be beneficial for international readers.

Minor comments:

1. Add CU5 abbreviation

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #4: No

Reviewer #5: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: review_PlOSone_rh.docx

PLoS One. 2023 Mar 31;18(3):e0283760. doi: 10.1371/journal.pone.0283760.r006

Author response to Decision Letter 2


15 Mar 2023

As per email correspondence we have disregarded the comments of Reviewer 4 and respond to Reviewer 5: Thanks for your additional review of our paper. We have further revised our paper accordingly. Please find our responses below each point in blue text.

Reviewer #5: This paper used 2014 UNICEF Malawi Multiple Cluster Indicator Survey to analyse socio economic predictors for RARI un CU% and PCV uptake in children aged 1-36 months. I hope the authors find the following comments and suggestions helpful.

Major comments:

1. I would advise that the authors use the term "association" instead of "predictor" in the title and throughout the study, as "predictor" may mislead readers about the nature of the research conducted. In certain instances, the term "predictor" indicates to certain readers that causal analysis is performed. But in this paper's study, "endogeneity" is obviously overlooked. Therefore, it is more suitable to avoid the term "predictor" and instead use "association" in this context.

Authors response: Thank you, we have changed “predictor” to “association” throughout.

2. I would present a missing analysis, do a sensitivity analysis using imputed values for missing data, and report on how the analysis altered (if any) as a result.

Authors response: Please see our response to concerns about missing data in our previous revision (R2), which included the newly added (in R2) supplementary Table S1:

Authors response: thanks for this suggestion, we have now done this and added it as Table S1 in the supplementary material of our paper. This Table is the same as the first 5 columns of Table 2 of our paper, but with an added column for “missing data” on RARI, in addition to the “Yes” and “No” columns. From this, we can see that the proportion in each category of each variable missing data on RARI are similar – the proportion missing data on RARI only varies by 8 percentage points (e.g. for child age) or less across the categories of each socio-economic variable (Table S1). Therefore, our main RARI analysis (Table 2) is unlikely to be biased. We have added the following text on page 20 of our paper to explain this:

“We report socio-economic characteristics of those with missing data on RARI separately in supplementary Table S1 and find the proportion missing data on RARI only varies by 8 percentage points (e.g. for child age) or less across the categories of each socio-economic variable (Table S1), suggesting our analyses below are unlikely to be biased by this missing data.”

This sensitivity analysis strongly suggests that imputing missing data would not significantly alter our results or conclusions.

3. Clearly the PCV uptake impacts the RARI in children. Thus, in Table 2 I would add the PCV uptake variable as an independent variable in the analysis. Otherwise this will create omitted variable bias.

Authors response: As we explain in our paper, the PCV data is only available for children aged 1-36 months. Our RARI analysis is separate and for all children aged under 5 years old (0-59 months) therefore we can’t include PCV in this analysis as it would change the sample for our RARI analysis completely.

4. The price type of the fuel used for cooking might be used as an indication of socioeconomic class. I would advise grouping them as expensive, moderately priced, and inexpensive cooking fuels and using that variable instead of the actual cooking fuel (electricity, coal, wood etc) used.

Authors response: There is no data on how much the fuel costs in the dataset (MICS 2014) that we use or on how much fuel each household uses so we are unable to determine the amount spent on fuel accurately. We also already include wealth quintile in our analysis separately.

5. In PCV analysis it would be great and much more useful if a bivariate constabulary analysis of PCV uptake and socioeconomic indicators are reported.

Authors response: In Table 4 we already report results separately for each dose of PCV: PCV1, PCV2, and PCV3 by socio-economic indicators both bivariate for each variable, and multivariable. We are not familiar with “constabulary analysis” and can’t find reference to it online.

6. The discussion part might be enhanced by arguing in accordance with the policy context and comparing the findings to those of other nations. This would be beneficial for international readers.

Authors response: This study uses nationally representative data from Malawi only and is therefore highly specific to the Malawian context. We therefore do not think it is appropriate to compare with policies of other countries, and the manuscript is already very long.

Minor comments:

1. Add CU5 abbreviation

Authors response: Thank you, we have added CU5 to our list of abbreviations, and added it in brackets after “children under 5” the first time it is mentioned in the abstract.

Attachment

Submitted filename: Response to reviewer 5 Gosling ARI.docx

Decision Letter 3

Shinya Tsuzuki

16 Mar 2023

What is associated with reported acute respiratory infection in children under 5 and PCV vaccination in children aged 1-36 months in Malawi? A secondary data analysis using the Malawi 2014 MICS survey

PONE-D-21-21665R3

Dear Dr. Colbourn,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Shinya Tsuzuki, MD, MSc

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Shinya Tsuzuki

23 Mar 2023

PONE-D-21-21665R3

What is associated with reported acute respiratory infection in children under 5 and PCV vaccination in children aged 1-36 months in Malawi? A secondary data analysis using the Malawi 2014 MICS survey

Dear Dr. Colbourn:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Shinya Tsuzuki

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (DOCX)

    S1 Data

    (DO)

    S1 Dataset

    (DTA)

    Attachment

    Submitted filename: PLOS ONE Review ARI MICs PCV Vax Malawi 06JUne2022.pdf

    Attachment

    Submitted filename: Response to Reviewers (Gosling Malawi ARI PLOS ONE).docx

    Attachment

    Submitted filename: Revision.docx

    Attachment

    Submitted filename: Response to Reviewers Gosling Colbourn PLOS ONE R2.docx

    Attachment

    Submitted filename: review_PlOSone_rh.docx

    Attachment

    Submitted filename: Response to reviewer 5 Gosling ARI.docx

    Data Availability Statement

    We used data from the 2014 UNICEF Malawi Multiple Indicator Cluster Survey (https://mics.unicef.org/surveys), which is freely available online. From this we created a minimal data set which we include in the Supporting information files. We also include, as Supporting information, Stata code used to create the minimal data set from the MICS 2014 datasets and reproduce the analyses in the paper.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES